We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Penumbra’s Indigo System Meets Primary Endpoint in Study in High Thrombus Patients
Penumbra’s Indigo System Meets Primary Endpoint in Study in High Thrombus Patients
Penumbra’s Indigo System CAT RX catheter met the primary endpoint in the “Cheetah” postmarket clinical study, demonstrating high rates of blood clot removal, blood flow restoration and myocardial perfusion in conjunction with percutaneous coronary intervention in patients with high thrombus burden, the company said Friday.